The SeattleStatGROWS program (Statistical Growing Research Opportunities for Undergraduates in Washington State) is a Fred ...

In this episode of Oncology Insights, Dr. Petros Grivas and Dr. Rachael Safyan discuss the advancements in gastrointestinal ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...

After surgery for prostate cancer, Todd Elworthy’s PSA came back elevated. Radiation was advised as the next step and Elworthy looked into a Fred Hutch clinical trial and proton therapy. Though he ...

ASH will recognize Rainer Storb, MD, with the Wallace H. Coulter Award for Lifetime Achievement in Hematology, the society's highest honor. See below for summaries and links to selected Fred Hutch ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Fred Hutch's Value in Cancer Care conference, held November 6, focused on patient and provider burnout; the growing data ...

GVHD can range from mild and temporary to life-threatening and chronic — but the deadly, debilitating cases are rare now. As ...

Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...

Philanthropy fuels Fred Hutch’s breakthroughs. Our community's support drives life-changing discoveries, strengthens patient and caregiver experiences, and helps build the next generation of ...

The Institute for Prostate Cancer Research (IPCR) is a collaborative effort between Fred Hutch and UW Medicine. Together, we are a team of more than 40 scientists and scientist-clinicians in multiple ...